Loading clinical trials...
Loading clinical trials...
Safety and Protective Efficacy of Repeated Controlled Human Schistosoma Mansoni Infection
Conditions
Interventions
Schistosoma mansoni infection
Placebo mock infection
Locations
1
Netherlands
Leiden University Medical Center
Leiden, Netherlands
Start Date
October 29, 2021
Primary Completion Date
January 11, 2023
Completion Date
January 11, 2023
Last Updated
January 30, 2023
NCT07484256
NCT06311344
NCT07482215
NCT03910972
NCT06312462
NCT05292391
Lead Sponsor
Leiden University Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions